Figure 5. Synergism of FAK inhibitor and Ruxolitinib/Stattic.
(A-D) Median effect analysis showing the interaction between FAKi and Ruxolitinib or Stattic in Panc-1 (A-B) or KP2 (C-D), analyzed using Compusyn software.
Data represent the combined mean ± s.e.m of three independent experiments each performed in duplicate. Horizontal dotted lines indicate the boundaries for each interaction classification.